Nicotine Lozenge
Product Images NDC 30142-124

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Nicotine (NDC 30142-124). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Kroger Company, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

124 45 Nicotine Lozenge Image 1

This is a description of a nicotine lozenge designed to aid quitting smoking. The lozenge contains 2mg of nicotine polacrilex and is cherry-flavored. It is intended to be used by individuals who smoke their first cigarette more than 30 minutes after waking up. The product is compared to the active ingredient found in "50 wor se o s, o cap s woen o wiss" and is labeled as a stop smoking aid. The packaging for the lozenges is described as containing 3Quitlubo® Comtalners Insido Inches s e.*

FDA Label Image

124 45 Nicotine Lozenge Image 2

FDA Label Image

Wallet_card (Image 01)

The text describes a wallet card that provides information about where to call for help related to lung disease, cancer, heart disease, and quitting smoking. The card contains phone numbers for the American Lung Association, American Cancer Society, and American Heart Association, as well as a suggestion to seek support from a quitting buddy or friend who has quit smoking.*

FDA Label Image

Wallet‑_card (Image 02)

FDA Label Image

Smoke_free_logo (Image 03)

FDA Label Image

Upc_example (Image 04)

FDA Label Image

Stickers (Image 05)

This appears to be a set of reminders for someone who wants to quit smoking. The reminders include specific times and frequencies for using lozenges as a step towards becoming an ex-smoker. The first reminder is to use one lozenge every 1 to 2 hours at the start of the quitting process, with a later reminder to decrease to 1 lozenge every 2 to 4 hours. The third step involves using one lozenge every 4 to 8 hours. The final reminder is for 12 weeks after quitting, although the purpose of this reminder is not clear from the text provided.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.